Article

Met Mutation is a Potential Therapeutic Target for Advanced Endometrial Cancer 

2020-09-28

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>An optimal therapeutic regimen for endometrial cancer with extra-uterine metastasis is unavailable. This study aimed to improve our understanding about the genomic landscape of advanced endometrial cancer and identify potential therapeutic targets.<bold>Methods</bold>The clinical and genomic profiles of 81 patients with stage III or IV endometrial cancer were inte...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: eba20322-3b01-5da8-a679-d56e4abe9fc3
DOI: 10.21203/rs.3.rs-80612/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Met Mutation is a Potential Therapeutic Target for Advanced Endometrial Cancer DOI 10.21203/rs.3.rs-80612/v1Read

Clinical Relevance of Oncogenic Driver Mutations Identified in Endometrial CarcinomaSemantic proximity Read

Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target TherapySemantic proximity Read

[Thoughts on the molecular characteristics of endometrial cancer in clinical diagnosis and treatment].Semantic proximity Read

New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere.Semantic proximity Read

The mutational landscape of endometrial cancer.Semantic proximity Read

Clinical relevance of oncogenic driver mutations identified in endometrial carcinomaSemantic proximity Read

Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection.Semantic proximity Read

Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment ChangesSemantic proximity Read

Genetic alterations in endometrial cancer by targeted next-generation sequencing.Semantic proximity Read

Molecular Landscape of Advanced Endometrial Cancer: Exploratory Analyses at Modena Cancer Center (MEMO).Semantic proximity Read

Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments.Semantic proximity Read

Identification of novel mutations in endometrial cancer patients by whole-exome sequencing.Semantic proximity Read